• No results found

PRAVASTATIN THERAPY AND THE RISK OF STROKE

Neuroimaging markers of hemorrhagic risk with stroke reperfusion therapy

Neuroimaging markers of hemorrhagic risk with stroke reperfusion therapy

... Perfusion imaging has shown promise in the pre- diction of salvageable brain tissue in ischemic stroke and also in hemorrhagic risk prediction. Studies with CT perfusion and PWI suggest that large areas of ...

6

Oral Anticoagulant Therapy in Atrial Fibrillation Patients at High Stroke and Bleeding Risk

Oral Anticoagulant Therapy in Atrial Fibrillation Patients at High Stroke and Bleeding Risk

... the risk of falling, or anticipated non-adherence to therapy (secondary to the need for regular INR monitoring or cognitive impairment) [35-37] resulting in a poor quality of warfarin therapy as ...

50

Smoking and the risk of stroke

Smoking and the risk of stroke

... cause stroke? When you smoke, you inhale tobacco smoke, which contains over 7,000 toxic chemicals including carbon monoxide, formaldehyde and hydrogen ...your risk of ...

6

STROKE SERIES SS3 REDUCING THE RISK OF STROKE

STROKE SERIES SS3 REDUCING THE RISK OF STROKE

... a stroke or TIA, and the doctor has established that it was not caused by a bleed, it is extremely likely that you will be given some kind of blood thinning ...the risk of further ...

40

Exploring the interaction between SNP genotype and postmenopausal hormone therapy effects on stroke risk

Exploring the interaction between SNP genotype and postmenopausal hormone therapy effects on stroke risk

... total stroke and for ischemic stroke ...hemorrhagic stroke events is too small for any clear ...increased risk of ischemic stroke by about half, with little evidence of an HT effect on ...

9

Risk factors associated with 90-day recurrent stroke in patients on dual antiplatelet therapy for minor stroke or high-risk TIA: a subgroup analysis of the CHANCE trial

Risk factors associated with 90-day recurrent stroke in patients on dual antiplatelet therapy for minor stroke or high-risk TIA: a subgroup analysis of the CHANCE trial

... lipid-lowering therapy was also included into the analysis, but the study also had some ...with stroke. Second, age and diabetes established and validated in risk models of ABCD2 were not identified ...

8

Statin therapy reduces oxidized low density lipoprotein level, a risk factor for stroke outcome

Statin therapy reduces oxidized low density lipoprotein level, a risk factor for stroke outcome

... statin therapy had lower Ox-LDL levels than those not receiving statin therapy since day 7 after ...ischemic stroke was significantly and independently pre- dictive of three-month outcome, and any ...

8

Stroke Risk Assessment Tool

Stroke Risk Assessment Tool

... No Each box that applies to you equals 1 point. Total your score at the bottom of each column and compare with the stroke risk levels at the bottom of the page. If your RED score is 3 or more, please ask ...

8

Perception of stroke and knowledge of potential risk factors among Omani patients at increased risk for stroke

Perception of stroke and knowledge of potential risk factors among Omani patients at increased risk for stroke

... of stroke mentioned by sub- jects in our study was weakness and paralysis of one side of the body ...acute stroke, reported that the most commonly documented stroke warning sign was ...common ...

6

Diuretic therapy, the alpha-adducin variant, and the risk of myocardial infarction or stroke in persons with treated hypertension

Diuretic therapy, the alpha-adducin variant, and the risk of myocardial infarction or stroke in persons with treated hypertension

... was first described äs a cause of hyper- tension in a series of elegant expen- ments on the Milan hypertensive strain M A cytoskeletal protein, adducin is a het- erodimer or heterotetra[r] ...

10

Blood Pressure Variability and Cardiovascular Risk in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER).

Blood Pressure Variability and Cardiovascular Risk in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER).

... The present study reveals some differences in the association between variability in the different blood pressure measurement and outcomes and shows some differences with previous research. One of the major differences ...

9

Homocysteine Levels and Treatment Effect in the Prospective Study of Pravastatin in the Elderly at Risk

Homocysteine Levels and Treatment Effect in the Prospective Study of Pravastatin in the Elderly at Risk

... cardiovascular risk and corresponding benefit from treatment can be ...cardiovascular risk but not the rela- tive CHD risk benefits of pravastatin ...from pravastatin therapy for ...

9

Pravastatin therapy during preeclampsia prevents long-term adverse health effects in mice

Pravastatin therapy during preeclampsia prevents long-term adverse health effects in mice

... at risk and allow for targeted sur- veillance and preventive therapy instigated during ...Since pravastatin therapy given during PE prevents long-term health compromise, it is tempting to ...

17

A Prospective Study of Pravastatin in the Elderly at Risk (PROSPER): Screening Experience and Baseline Characteristics

A Prospective Study of Pravastatin in the Elderly at Risk (PROSPER): Screening Experience and Baseline Characteristics

... of Pravastatin in the Elderly at Risk (PROSPER) is a randomised, double blind, place- bo-controlled trial to test the hypothesis that treatment with pravastatin will diminish the risk of ...

8

Update on cell therapy for stroke

Update on cell therapy for stroke

... cell therapy for stroke extended the results of the early intraparenchymal studies to additional routes of ...the risk of multiorgan exposure and require infusion of higher cell ...Intra-arterial ...

6

Exosomes in stroke pathogenesis and therapy

Exosomes in stroke pathogenesis and therapy

... Introduction Stroke is one of leading causes of death and disability worldwide ...with stroke within ...after stroke onset by rapidly recanalyzing the occluded blood vessels and reestablishing tis- ...

9

Exosomes in stroke pathogenesis and therapy

Exosomes in stroke pathogenesis and therapy

... Introduction Stroke is one of leading causes of death and disability worldwide ...with stroke within ...after stroke onset by rapidly recanalyzing the occluded blood vessels and reestablishing tis- ...

9

Role of occupational therapy after stroke

Role of occupational therapy after stroke

... of stroke, and close to the time of hospital discharge, the occupational therapist will examine the patient’s capacity to complete their usual activities, to manage safely in their own home environment, and to ...

10

Is there a link between aspirin therapy and stroke severity

Is there a link between aspirin therapy and stroke severity

... the risk of events, but also decrease their severity and improve ...ischemic stroke, perhaps by reducing thrombus size or propagation, or because it represents a marker of treatment ...

5

Hyperbaric oxygen therapy in post-stroke patients

Hyperbaric oxygen therapy in post-stroke patients

... ischemic stroke - medical management, risk factors, nutrients, and other interventions for managing inflammation and enhancing brain ...oxygenation therapy on prognosis and oxidative stress of acute ...

5

Show all 10000 documents...

Related subjects